Patents by Inventor Christopher M. M. Franco

Christopher M. M. Franco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5271935
    Abstract: Cammunocin, an active substance which can be obtained by cultivation of Streptomyces species Y-84,36210 (DSM 4329), has antibiotic and immunosuppressant activity.
    Type: Grant
    Filed: March 13, 1992
    Date of Patent: December 21, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Sugata Chatterjee, Erra K. S. Vijayakumar, Bimal N. Ganguli, Richard H. Rupp
  • Patent number: 5270182
    Abstract: The novel compounds of formulas I and II ##STR1## have an antibiotic activity.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: December 14, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Dilip J. Upadhyay, Louis E. L. Coutinho, Bimal N. Ganguli, Jurgen Blumbach, Hans-Wolfram Fehlhaber, Herbert Kogler
  • Patent number: 5162368
    Abstract: Butalactin, a compound of the formula I ##STR1## can be produced by cultivation of Streptomyces species Y-86,36923. Butalactin has an antibiotic activity.
    Type: Grant
    Filed: August 6, 1990
    Date of Patent: November 10, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Erra K. Vijayakumar, Sugata Chatterjee, Bimal N. Ganguli, Jurgen Blumbach
  • Patent number: 5114967
    Abstract: Alisamycin, a compound of the formula I ##STR1## has an antibiotic, antitumor and antiparasitic action.
    Type: Grant
    Filed: January 10, 1991
    Date of Patent: May 19, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Erra K. S. Vijayakumar, Sugata Chatterjee, Bimal N. Ganguli, Jurgen Blumbach, Herbert Kogler, Hans-Wolfram Fehlhaber
  • Patent number: 4988677
    Abstract: The present invention relates to the macrolide antibiotic swalpamycin, to a microbiological process for its preparation, to a new microorganism strain Streptomyces species, and to the use of swalpamycin as a medicinal agent for the treatment of infections caused by bacteria, mycoplasmas and Actinomycetes.
    Type: Grant
    Filed: August 25, 1987
    Date of Patent: January 29, 1991
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Julia Gandhi, Sugata Chatterjee, Goukanapalli C. S. Reddy, Bimal N. Ganguli, Richard H. Rupp, Herbert Kogler, Hans-Wolfram Fehlhaber
  • Patent number: 4738958
    Abstract: The present invention relates to the compound naphthomycin H of the formula I ##STR1## and to a microbiological process for its preparation. The compound is active against Gram-positive bacteria and fungi and can be used as an antibiotic.
    Type: Grant
    Filed: April 1, 1986
    Date of Patent: April 19, 1988
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Goukanapalli C. S. Reddy, Triptikumar Mukhopadhyay, Bimal N. Ganguli, Hans-Wolfram Fehlhaber